Hany F Sobhi Selected Research

Palmitoylcarnitine

1/2020	Carnitine palmitoyltransferase 2 knockout potentiates palmitate-induced insulin resistance in C2C12 myotubes.
1/2014	The mechanism of Intralipid®-mediated cardioprotection complex IV inhibition by the active metabolite, palmitoylcarnitine, generates reactive oxygen species and activates reperfusion injury salvage kinases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hany F Sobhi Research Topics

Disease

2	Reperfusion Injury 01/2014 - 01/2014
1	Inflammation (Inflammations) 01/2020
1	Insulin Resistance 01/2020
1	Ischemia 01/2014

Drug/Important Bio-Agent (IBA)

2	PalmitoylcarnitineIBA 01/2020 - 01/2014
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	PalmitatesIBA 01/2020
1	Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2014
1	FructoseIBA 01/2014
1	Phosphotransferases (Kinase)IBA 01/2014
1	Sevoflurane (Ultane)FDA LinkGeneric 01/2014